NOVAVAX INC - Common Stock (NVAX) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2016 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
NVAX on Nasdaq
Shares outstanding
163,049,608
Price per share
$9.44
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
117,756,380
Total reported value
$791,346,585
% of total 13F portfolios
0%
Share change
+14,247,194
Value change
+$80,329,867
Number of holders
231
Price from insider filings
$9.44
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NOVAVAX INC - Common Stock (NVAX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SHAH CAPITAL MANAGEMENT 8.3% +14% $116,713,633 +$14,305,500 13,461,780 +14% Himanshu H. Shah 10 Nov 2025
BlackRock, Inc. 8.4% $90,252,258 13,450,411 BlackRock, Inc. 31 Dec 2024
STATE STREET CORP 5.9% $82,570,011 9,523,646 STATE STREET CORPORATION 31 Dec 2025
BANK OF AMERICA CORP /DE/ 5.1% $72,095,645 8,315,530 BANK OF AMERICA CORP /DE/ 31 Dec 2025

As of 31 Dec 2025, 231 institutional investors reported holding 117,756,380 shares of NOVAVAX INC - Common Stock (NVAX). This represents 72% of the company’s total 163,049,608 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of NOVAVAX INC - Common Stock (NVAX) together control 65% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 9.5% 15,470,365 +1.8% 0% $103,960,853
SHAH CAPITAL MANAGEMENT 8.9% 14,558,780 +23% 19% $97,835,002
BlackRock, Inc. 7.9% 12,901,549 +1% 0% $86,698,409
STATE STREET CORP 5.8% 9,523,646 +32% 0% $63,998,901
BANK OF AMERICA CORP /DE/ 5.1% 8,290,665 +167% 0% $55,713,268
Sanofi 4.2% 6,880,481 0% 15% $46,236,832
D. E. Shaw & Co., Inc. 3.7% 5,992,798 +40% 0.03% $40,271,603
UBS Group AG 3% 4,894,284 +39% 0.01% $32,889,587
MILLENNIUM MANAGEMENT LLC 2.7% 4,470,083 +110% 0.02% $30,038,958
GEODE CAPITAL MANAGEMENT, LLC 2.3% 3,721,323 -1.9% 0% $25,012,096
MORGAN STANLEY 2.3% 3,717,984 +245% 0% $24,984,861
Allianz Asset Management GmbH 1.4% 2,324,142 +65% 0.02% $15,618,234
NORTHERN TRUST CORP 0.89% 1,453,976 -4.9% 0% $9,770,718
TSP Capital Management Group, LLC 0.85% 1,389,065 2.3% $9,334,517
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.82% 1,335,053 +0.28% 0% $8,971,556
BARCLAYS PLC 0.68% 1,102,300 +109% 0% $7,407,455
GOLDMAN SACHS GROUP INC 0.67% 1,090,559 +38% 0% $7,328,557
CITADEL ADVISORS LLC 0.66% 1,073,727 -16% 0% $7,215,446
Monaco Asset Management SAM 0.64% 1,045,000 +161% 2.1% $7,022,400
SG Americas Securities, LLC 0.6% 976,388 +6.3% 0.01% $6,561,000
MARSHALL WACE, LLP 0.57% 929,611 +1737% 0.01% $6,246,985
HRT FINANCIAL LP 0.51% 834,223 -33% 0.02% $5,605,000
Bank of New York Mellon Corp 0.49% 796,319 +63% 0% $5,351,268
TWO SIGMA INVESTMENTS, LP 0.38% 623,812 -11% 0.01% $4,192,017
JANE STREET GROUP, LLC 0.32% 517,643 -19% 0% $3,478,561

Institutional Holders of NOVAVAX INC - Common Stock (NVAX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 117,756,380 $791,346,585 +$80,329,867 $6.72 231
2025 Q3 103,212,737 $894,644,529 +$22,681,902 $8.67 244
2025 Q2 101,926,921 $642,596,235 +$26,723,556 $6.30 245
2025 Q1 98,489,289 $631,402,819 -$31,743,582 $6.41 239
2024 Q4 102,621,538 $825,131,401 -$12,498,087 $8.04 226
2024 Q3 93,728,334 $1,185,512,029 +$128,224,618 $12.63 225
2024 Q2 83,464,759 $1,059,918,322 +$101,312,152 $12.66 220
2024 Q1 75,527,682 $361,018,382 -$3,812,627 $4.78 189
2023 Q4 76,725,820 $368,301,338 +$60,349,311 $4.80 191
2023 Q3 61,747,470 $447,039,158 +$35,454,803 $7.24 218
2023 Q2 56,705,546 $421,251,592 -$21,077,107 $7.43 202
2023 Q1 60,022,038 $415,977,902 +$24,129,521 $6.93 208
2022 Q4 52,556,924 $540,013,841 +$137,141,602 $10.28 236
2022 Q3 36,188,483 $658,924,088 -$41,541,447 $18.20 214
2022 Q2 33,896,260 $1,743,667,465 -$19,484,059 $51.43 288
2022 Q1 33,373,084 $2,458,716,103 -$55,536,369 $73.65 346
2021 Q4 33,397,602 $4,783,479,130 -$707,719,453 $143.07 399
2021 Q3 37,367,414 $7,745,430,573 -$523,926,966 $207.31 412
2021 Q2 39,714,489 $8,429,599,286 -$519,994,166 $212.31 394
2021 Q1 42,385,643 $7,684,705,204 +$831,207,087 $181.31 369
2020 Q4 38,737,001 $4,320,546,392 +$723,829,689 $111.51 327
2020 Q3 32,274,360 $3,495,919,877 +$140,194,009 $108.35 299
2020 Q2 28,744,068 $2,396,362,967 +$1,445,662,354 $83.35 206
2020 Q1 13,157,554 $178,738,588 +$88,861,816 $13.58 107
2019 Q4 6,654,109 $26,481,422 -$2,172,783 $3.98 65
2019 Q3 7,027,240 $35,282,234 +$1,163,958 $5.02 69
2019 Q2 6,731,130 $39,449,216 +$30,447,257 $5.86 70
2019 Q1 4,357,294 $2,534,000 +$2,400,000 $0.55 4
2016 Q4 0 $0 -$2,080 $9.44 0
2016 Q3 1,000 $2,080 $2.08 1
2016 Q2 1,000 $7,270 +$7,270 $7.27 1